In 1996 was created Cardinal Partners, which is appeared as VC. The venture was found in North America in United States. The main department of described VC is located in the Princeton.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Vividion Therapeutics, Ivenix, lifeIMAGE.
The important activity for fund was in 2011. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. Comparing to the other companies, this Cardinal Partners performs on 4 percentage points less the average number of lead investments. The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2012. The average startup value when the investment from Cardinal Partners is 50-100 millions dollars.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Cardinal Partners, startups are often financed by Venrock, Polaris Partners, Avalon Ventures. The meaningful sponsors for the fund in investment in the same round are Venrock, Icon Ventures, Sequel Venture Partners. In the next rounds fund is usually obtained by Polaris Partners, Icon Ventures, Venrock.
The fund was created by Brandon H. Hull. The overall number of key employees were 3.
Related Funds
Funds with similar focus
Fund Name | Location |
Association of Otolaryngology | Pennsylvania, Pittsburgh, United States |
Bluehill | California, San Francisco, United States |
Fuyo General Lease | Chiyoda, Japan |
Greenfield Partners | Israel, Tel Aviv, Tel Aviv District |
K50 Ventures | New York, New York, United States |
Merlin Nexus | New York, New York, United States |
Titan Capital | Gurgaon, Haryana, India |
Urrshila Kerkar | - |
Xunzhao Zhongguo Chuangke | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Vividion Therapeutics | $82M | 30 Apr 2019 | San Diego, California, United States | ||
Prealize Health | $6M | 27 Sep 2017 | Palo Alto, California, United States | ||
Vividion Therapeutics | $50M | 02 Feb 2017 | San Diego, California, United States | ||
Vividion Therapeutics | $3M | 11 Apr 2016 | San Diego, California, United States | ||
Cureatr | $13M | 25 Jun 2015 | New York, New York, United States | ||
Teladoc Health | $50M | 18 Sep 2014 | Purchase, New York, United States | ||
Cureatr | $5M | 23 Oct 2013 | New York, United States | ||
Sapphire Digital | $22M | 18 Jun 2013 | New Jersey, United States | ||
lifeIMAGE | $15M | 18 Apr 2013 | Newton, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Vividion Therapeutics | $82M | 30 Apr 2019 | San Diego, California, United States | ||
Prealize Health | $6M | 27 Sep 2017 | Palo Alto, California, United States | ||
Vividion Therapeutics | $50M | 02 Feb 2017 | San Diego, California, United States | ||
Vividion Therapeutics | $3M | 11 Apr 2016 | San Diego, California, United States | ||
Cureatr | $13M | 25 Jun 2015 | New York, New York, United States | ||
Teladoc Health | $50M | 18 Sep 2014 | Purchase, New York, United States | ||
Cureatr | $5M | 23 Oct 2013 | New York, United States | ||
Sapphire Digital | $22M | 18 Jun 2013 | New Jersey, United States | ||
lifeIMAGE | $15M | 18 Apr 2013 | Newton, Massachusetts, United States |